Faced with no guidelines for treating delirium in COVID-19 patients, colleagues in the Department of Psychiatry at Massachusetts General Hospital set out to provide pharmacologic recommendations—based on the experiences of C-L psychiatrists managing patients with the virus.

Read more: https://www.clpsychiatry.org/aclp-news/y2020/m12/covid19-delirium/

Return to news archive